Kevin Slawin is Director, Vanguard Urologic Institute and the Texas Prostate Center; Professor, Center for Clinical and Translational Sciences, UTHSC-Houston; Clinical Professor of Urology, Baylor College of Medicine; and Director of Urology, Memorial Hermann Hospital – TMC. He is a pioneer in the field of robotic surgery, co-inventor of the [-2]proPSA prostate cancer screening test, and a thought leader in the diagnosis and treatment of prostate cancer. As CMO, Dr Slawin has strategic responsibility for the company’s clinical activities.
